Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors

  1. Lookup NU author(s)
  2. Dr Peter Stephens
  3. Professor Alan Calvert
  4. Professor Ruth Plummer
Author(s)Yap TA, Vidal L, Adam J, Stephens P, Spicer J, Shaw H, Ang J, Temple G, Bell S, Shahidi M, Uttenreuther-Fischer M, Stopfer P, Futreal A, Calvert H, de Bono J, Plummer R
Publication type Article
JournalJournal of Clinical Oncology
Year2010
Volume28
Issue25
Pages3965-3972
ISSN (print)0732-183X
ISSN (electronic)1527-7755
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Society of Clinical Oncology
URLhttp://dx.doi.org/10.1200/JCO.2009.26.7278
DOI10.1200/JCO.2009.26.7278
Actions    Link to this publication